Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

Stool-based DNA testing can help bridge CRC screening gaps between rural and urban populations by providing timely follow-up. The study found no significant difference in follow-up times for ...

ORLANDO -- Patients with inflammatory bowel disease (IBD) reported mostly favorable responses with the use of mail-order kits for stool sample collections, according to a survey study. Among survey ...

(MENAFN- GlobeNewsWire - Nasdaq) The Global GI Stool Testing Market Size was Valued at USD 580.0 Million in 2023 and the Worldwide GI Stool Testing Market Size is Expected to Reach USD 1195 Million by ...

University of Edinburgh scientists developed a luminescent reporter that detected granzyme A activity in stool samples, ...

A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive and specific for detecting colorectal cancer (CRC) among Thai individuals.

Researchers in Edinburgh have developed a rapid stool-based test aiming to improve the diagnosis of inflammatory bowel ...

New York, United States , Aug. 21, 2024 (GLOBE NEWSWIRE) -- The Global GI Stool Testing Market Size is Expected to Grow from USD 580.0 Million in 2023 to USD 1195 Million by 2033, at a CAGR of 7.50% ...

Gastroenterology specialists Dr Andy Li and Dr Jessica Gurung outline a rational approach to investigating recurrent ...

Medicare should cover a parasite poop test when medically necessary, usually when a person has symptoms of gastroenteritis or a history of exposure to a parasite. Laboratory technicians perform a ...